Insider Trading

Notable insider buying and selling activity across public companies.

Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.

Articles

10,165 total articles

Starbucks Executive Sara Kelly Disposes of $210,000 in Common Stock

Starbucks Executive Sara Kelly Disposes of $210,000 in Common Stock

Sara Kelly, who serves as the executive vice president and chief partner officer at Starbucks Corp. (NASDAQ:SBUX), has completed a sale of 2,000 shares of the company's common stock. The transaction, which took place on April 29, 2026, resulted in total proceeds of $210,000 based on a sale price of $105.00 per share. This divestment occurred during…

Bancorp Executive Disposes of Over $269,000 in Company Stock

Bancorp Executive Disposes of Over $269,000 in Company Stock

A recent regulatory filing has revealed that Erika R. Caesar, the Executive Vice President and General Counsel of Bancorp, Inc. (NASDAQ:TBBK), has completed a sale of her company stock. The transaction, which took place on April 29, 2026, involved the disposal of 4,470 shares of Bancorp common stock. The total value of this divestment is estimated …

Bancorp Executive Maria Wainwright Executes Common Stock Sale

Bancorp Executive Maria Wainwright Executes Common Stock Sale

Maria Wainwright, who serves as the Executive Vice President and Chief Marketing Officer at Bancorp, Inc. (NASDAQ: TBBK), has completed a sale of company common stock. The transaction, occurring on April 28, 2026, involved 8,400 shares and resulted in total proceeds of $506,020. This move follows a first-quarter earnings report that presented a div…

Nurix Therapeutics CLO Executes Stock Transactions Amid RSU Vesting

Nurix Therapeutics CLO Executes Stock Transactions Amid RSU Vesting

Christine Ring, the Chief Legal Officer at Nurix Therapeutics, Inc. (NASDAQ: NRIX), recently engaged in transactions involving company common stock. Following the vesting of restricted stock units, Ms. Ring acquired 8,608 shares and subsequently sold 3,214 shares to satisfy tax withholding requirements. This activity occurred against a backdrop of …

Nurix Therapeutics CFO Executes Stock Transactions Amid RSU Vesting

Nurix Therapeutics CFO Executes Stock Transactions Amid RSU Vesting

Hans van Houte, the Chief Financial Officer of Nurix Therapeutics, Inc. (NASDAQ:NRIX), completed several equity transactions on April 30, 2026. The activity involved both the acquisition of new shares through the vesting of restricted stock units (RSUs) and a sale of existing shares to address tax-related requirements. While the sale represents a r…

Nurix Therapeutics CSO Executes Stock Sale Related to RSU Vesting

Nurix Therapeutics CSO Executes Stock Sale Related to RSU Vesting

Gwenn Hansen, the Chief Scientific Officer at Nurix Therapeutics, Inc. (NASDAQ:NRIX), conducted a series of transactions involving company common stock on April 30, 2026. These actions included the sale of 3,214 shares to meet tax withholding requirements and the acquisition of 8,608 shares through the vesting of restricted stock units (RSUs). Foll…